Type 1 Research Today

Similar documents
STRATEGIC PLAN

Eradicating cervical cancer. Our role in making it a reality

Agenda 2030: One Nation Labour s Plan for science Response from Alzheimer s Research UK

Moorfields Eye Charity Strategy People's sight matters

Together to beat MS Renewing our local networks

Alcohol Research UK Research Strategy

stroke.org.uk Supporting world-class stroke research in Scotland

NIHR Supporting collaboration in life sciences research

Biomedical Research Strategy Making sure there are effective treatments for deafness, hearing loss and tinnitus

ABOUT THIS DOCUMENT WHAT WE DO

Ambitious Futures 2020 Strategy

Strategic Plan

Published December 2015

Tuberous Sclerosis Australia Strategic Plan

finding cures for all cancers

The Road Ahead Strategy

Young People. & Brexit. New Age for. democracy. Our. Living. Minds. Wage for Everyone. Matter. Save our. Youth. Teach. Services. First Aid.

Creating the change. Homeless Link s strategy to end homelessness. June 2018 to June 2021

Chest Heart & Stroke Scotland Research Strategy

MRCG Strategic Document

Research strategy

Strategy Registered Charity

A future where everybody who develops breast cancer lives and lives well. Our vision, mission, values and five-year strategy ( )

A Youth Sector Summary of the Civil Society Strategy. Youth Work Youth Participation Funding for Young People NCS

Research Strategy

Implications for public health research. Professor Bernie Hannigan Director - Research, Translation & Innovation

Making social action part of life for all young people by 2020

Carers Australia Strategic Plan

POTENTIAL FOR MERGER: THE BRAIN TUMOUR CHARITY SECTOR

CARDIFF RESEARCH OPEN DAY FOCUS ON CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL)

Job information pack COMMUNITY COORDINATOR (Northern Ireland)

SAVING LIVES: ACHIEVING MORE

An Active Inclusive Capital. A Strategic Plan of Action for Disability in London

Overcoming barriers. Our strategy for

National Dementia Vision for Wales Dementia Supportive Communities

Child Brain Injury Trust Our 5 Year Plan

DOING IT YOUR WAY TOGETHER S STRATEGY 2014/ /19

Strategic Direction. At The Kids Cancer Project our vision is to find a cure for kids cancer

Foreword. Our shared principles

POSI IVE PROGRESS IMPACT REPORT 2017

Momentum Awards: Institutional pumppriming awards for dementia research

Chairman s Report January 2016

Pancreat ic Cancer UK. policy briefing. A cancer of unmet need: the pancreatic cancer research challenge

ASSOCIATE MEMBERSHIP SCHEME

Darran Martin. Moving forward. First Homeless Rugby session in Regents Park, Autumn 2013.

ViiV Healthcare s Position on Continuous Innovation in Prevention, Testing, Treatment & Care of HIV

British Society for Immunology. Corporate Membership Packages

NIHR Leeds Clinical Research Facility Patient and Public Involvement Strategy

A guide to making a Will and including a gift to Parkinson s UK

Consultation on Australian Medical Research and Innovation Priorities for

our aberlour Supporting Children and Families Earlier

stroke.org.uk Impact report

Championing patients every step of the way

MCF Strategy

Join us. Corporate Membership. Bone Health Partnership. Working together for a brighter future for people with or at risk of osteoporosis

What needs to happen in England

Strategic Plan

Waterloo Wellington Regional Renal Program. Renal Plan

Patient and Public Involvement, Engagement and Participation Strategy NIHR Newcastle Clinical Research Facility

JOB DESCRIPTION JOB TITLE: STATUS: HOURS: SALARY: HOLIDAY: LOCATION: REPORTS TO: DIRECT REPORTS: KEY INTERNAL RELATIONSHIPS:

A voice for positive change in NHS Wales

Defeat Dementia. Five years and 100m of investment to power transformational patient benefit

TRUSTEE RECRUITMENT PACK

2. The role of CCG lay members and non-executive directors

Moorfields Research and Innovation. Participating in research at Moorfields Eye Hospital NHS Foundation Trust. hope trust care

The Triangle of Care, Carers Included

CANDIDATE PACK. Trustee

Our approach to research

Adding Value to the NHS, Health and Care, through Research Management, Support & Leadership

ENABLE Scotland. Inverness ACE. Annual Report 2017

LPI : Leadership Practices Inventory

First and foremost we have the world s largest privately funded biomedical research group investing about $8 billion in 2008.

Driving Improvement in Healthcare Our Strategy

WHF Salim Yusuf Emerging Leaders Programme

Heritage Trust Network

Volunteering in sport A framework for volunteering: at the heart of Scottish sport

Ways to Wellbeing. Social Prescribing Programme. Social Impact Report Report produced by:

Service Coordinator British Red Cross and Macmillan Support at Home Service

UICC Members Regional Meeting. North America & Global Collaborations

Vision 2025: Summary

Our 2011 achievements

Breast Cancer Now Information Pack for Trustee Recruitment

ENABLE Scotland. East Dunbartonshire ACE Youth. Annual Report 2017

Youth Democracy Coordinator- Midlands

EVENTS MANAGER CYCLE TO THE MOON, SAVE A DAD

Evaluation report for The Advocacy Project. Executive Summary

Communications Manager

STRATEGIC PLAN

Dear members of the Year One programme of the Leadership Development Project,

Speech by The Rt Hon David Cameron

DCP Newsletter. Welcome. Issue 1 June Key Dates. National Men s Health Week June 2018

What needs to happen in Scotland

The Ayrshire Hospice

SECTION 3: WHAT DOES DIABETES UK DO?

TESTING TIMES TO COME? AN EVALUATION OF PATHOLOGY CAPACITY IN NORTHERN IRELAND NOVEMBER 2016

I hope this guide will be a useful tool to help us excel in all we do.

Strategic framework

STRATEGIC PLAN. Working to address health inequalities and improve the lives of LGBT people in Scotland

THE MICHAEL J. FOX FOUNDATION FOR PARKINSON S RESEARCH. Funding Opportunities

NHS Youth Forum Coordinator

Transcription:

Type 1 Research Today A healthy landscape for supporting type 1 diabetes research jdrf.org.uk

UK funding organisations are investing close to 100 million in type 1 research This is testament to the quality of the UK type 1 research community. Funding organisations report that the success rate for type 1 diabetes applications is broadly in line with that for other conditions, although some report that they receive fewer type 1 applications than might be expected. To ensure that type 1 research continues to play a strong role in making the UK a leader in medical research, every effort should be made to ensure that this healthy ecosystem of funding opportunities remains strong and protected. 25,525,377 22,886,054 16,270,836 13,517,941 JDRF Awards 33 NIHR Awards 29 Wellcome Trust Awards 10 Diabetes UK Awards 50 11,233,000 6,319,969 Medical Research Council Awards 18 Innovate UK Awards 8 1,490,438 Chief Scientists Office Awards 8 Total number of active awards 156 Total amount active (committed funding) 97,243,615 Next step: Protect and strengthen the UK type 1 diabetes research funding ecosystem * Different organisations use different metrics and time periods in their reporting. The snapshot presented here represents data shared with JDRF for awards covering the organisations 2014/2015 or their last full year s funding (if their reporting year differs).

UK research funders cover the whole research pipeline Different research funding organisations cover different aspects of the research pipeline. From basic science and underpinning infrastructure through to clinical trials, there is an organisation willing and able to fund this work. CSO Diabetes UK Innovate UK JDRF MRC NIHR Wellcome Trust Basic Translational Clinical Not only do funders finance the research pipeline, but JDRF, CSO, Diabetes UK, MRC, NIHR and the Wellcome Trust also support resources which underpin and enable it, such as equipment and bioresources. Next step: The healthy mixture of basic, translational and clinical research we see can only remain strong if barriers to smooth movement of ideas along the pipeline are minimised. Organisations can work together more closely to address gaps and work in partnership ever more effectively. Type 1 diabetes research is being funded throughout the UK Institutions in each of the home nations appear in the top 10 for both number of projects and value of investment. The golden triangle is important in type 1 research, but London, Cambridge and Oxford do not dominate the type 1 research space in the same way as in other conditions. This not only provides a more diverse talent pool to work on type 1, but should also mean that people with type 1 will have opportunities to engage in research wherever they live in the UK. No. of research funding locations 1 4 5 10 11 + Next step: Type 1 research expertise can be found right across the UK. This diversity of institutions should be supported and preserved, while further collaboration between centres of excellence should be encouraged.

There are gaps in the types of research awards available in the UK The numbers of awards in certain areas show that there are very few designated awards for PhD studentships in type 1 diabetes and there are also few grants specifically for equipment. While many project grants may include funding for equipment and studentships, the lack of award schemes in these areas warrants further investigation. We need to ensure that type 1 research in the UK remains cutting edge and that we are training the next generation of researchers to tackle type 1 diabetes. Clinical lectureship Cohort/bioresource Fellowship Equipment PhD students Project/programme 45 40 35 30 25 20 15 10 5 0 Personal awards Underpinning research infrastructure Basic research Translational research Clinic trial Next step: Funders and researchers must talk openly to ensure that the research community can access the sorts of funding schemes needed to support type 1 diabetes science effectively.

Type 1 Research Today presents a picture of the UK funding environment for type 1 diabetes research. Since we began working with families affected by type 1 diabetes to advocate for investment in type 1 research, the investment in research to tackle type 1 has grown At the time of our first Type 1 Parliament, Government told us about 6.6 million of research investment that was relevant to type 1 diabetes. This was a significant underestimate: figures now available to us suggest that in 2012, Government funding agencies were supporting approximately 30 million of type 1 research. Today, our analysis shows investment of almost 42 million The Type 1 Research Today report was made possible by a generous individual gift from JDRF Patrons James and Margaret Cripps.

Join us to catalyse faster progress towards a world without type 1 diabetes Type 1 Research Today presents a positive picture of type 1 diabetes research in the UK. Many funders are engaged in supporting type 1 diabetes research, and UK researchers are making significant contributions to global progress in treating, preventing and ultimately curing type 1 diabetes. But our vision of a world free of type 1 diabetes is not yet reality. There is still a great deal more work to do in laboratories, hospitals, board rooms and debating chambers to make that dream come true. And whoever we are, we can each take steps to bring the day we consign type 1 to the history books closer. If you are a researcher: talk to research funders and apply. Have conversations with funding organisations to check that you are making the most of the opportunities available to you. Type 1 research has as good a success rate as any other type, across all the organisations we spoke to, so go for it! If you are a funder: listen to researchers. Guide them towards the most appropriate funding schemes for them. Talk to us at JDRF, and to other funders, about combining resources to drive forward type 1 research together. Think innovatively about how best to empower researchers to change the face of type 1 and ensure that funding schemes fit the needs of the research community and the type of research they wish to conduct. Consider designing new funding vehicles to support vital underpinning research or exciting new ways to tackle type 1 diabetes. If you are an MP: Government funding for type 1 diabetes research accounts for approaching half of the UK type 1 research portfolio. Its loss would be catastrophic. Support initiatives to maintain the UK s position as a leader in biomedical research. Recognise the vital role government funding bodies have in supporting the fundamental infrastructure required to drive innovation and attract investment, and campaign to ensure these are maintained and developed. If you are affected by type 1 diabetes: keep doing what you are doing. You are the reason that the picture of type 1 research today looks so positive. By participating in, fundraising for and spreading the word about type 1 diabetes research you have shaped the type 1 diabetes research landscape that we see today. Thank you for all you have done. Follow us on social media JDRF, 17/18 Angel Gate, City Road, London EC1V 2PT. T: 020 7713 2030, F: 020 7713 2031, E: publicaffairs@jdrf.org.uk Registered charity numbers 295716 (England and Wales) and SC040123 (Scotland). Company Limited No. 2071638.